Serinus Biosciences
YC S22 βNew York City, US Β· Founded 2022 Β· 6 employees Β· 3 known investors
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
Founders & leadershipΒ· Y Combinator alumni (S22)
AY
Adam YaariinπFounder/CEO
MS
Maxwell ShermaninπFounder/CTO
Investors Β· 3
In the news
- Serinus Biosciences Funding | $0-1M Revenue | Complete Analysis | Extruct AIextruct.ai Β· 2022
- Serinus Biosciences: Killing cancer with its own genetics πͺπ½ycombinator.com Β· 2022